You searched for "lid"

1816 results found

Intravitreal triamcinolone for uveitic macular oedema

This paper from South Korea reports on a prospective, double blind, randomised clinical study designed to evaluate the additional benefit of intravitreal triamcinolone (TA) administration for noninfectious uveitic macular oedema as an adjunct therapy to systemic anti-inflammatory treatment. Patients were...

Visual recovery following Ex-Press vs. trab

The authors describe a prospective randomised study of 64 POAG subjects with controlled IOPs comparing visual acuity data in patients randomised to either Ex-Press model P50 or trabeculectomy. Visual acuities were recorded at baseline, day one, weeks one and two...

Should intravitreal steroids be used in the initial treatment of post-op endophthalmitis?

Endophthalmitis following cataract surgery is one of the most feared complications, and can have significant impact on the visual outcomes of patients. The role of steroids in the management of endopthalmitis is controversial. The aim of this paper was to...

Corneal thickness in patients with diabetic peripheral neuropathy

This cross-sectional study assessed corneal thickness in association with diabetic peripheral neuropathy (DPN) severity. The study also tried to identify the layer of the cornea most affected by DPN status. Performed at the University of Michigan the study included three...

IOL power calculation formulas for myopic eyes undergoing cataract surgery after excimer laser

The authors set out to compare the accuracy of four no-history formulas: Barrett True-K, Haigis-L, Shammas-PL, and Triple-S to calculate the intraocular lens (IOL) power in eyes with previous myopic photorefractive keratectomy or laser in situ keratomileusis, according to their...

Corporate M&A pace gathers momentum

Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...

See sweet to C-suite: Peter Holland

See also - See sweet to C-suite: Imran Rahman In this three-part conversation series, Co-editor David Lockington speaks with highly influential individuals about their journey to the top, with advice for the next generation of leaders. Part One: David speaks...

The importance of ‘hands-on’ learning

Providing ongoing professional education and development for the allied professions out of the clinic or hospital setting is often quite challenging. The reorganisation of rotas, heavy clinic lists and financial constraints all add up to making the opportunity to learn...

SpaMedica extends its ophthalmic training programme, creating vital placements for NHS registrars

The UK’s largest provider of NHS cataract surgery is already supporting 60 aspiring surgeons, and has recently appointed three staff members to further develop its training provision.

Minister visits London special school to see SeeAbility eyecare team in action

Last month, disability charity SeeAbility had a special visitor to a very special school: Minister for Care, Stephen Kinnock MP. Stephen visited The Village School in London to see children receiving eye care from SeeAbility’s specialist team. He also got...

Protecting and recovering from email hacking

Over the last 12 months I have received emails from more than 20 friends and acquaintances (mostly doctors) who didn’t send those emails. More often than not I find the emails in my ‘Spam’ folder as Gmail knows they are...

GDPR, email and private practice

A new set of data protection regulations became law in the EU (including the UK) in May 2018. General Data Protection Regulation (GDPR) replaces the 1988 Data Protection Act. The regulation brings new rights and expectations about how our personal...